|
|
|
|
|
Day 1 - Wednesday 23rd September 2009 |
|
|
Business & Ethics
Session: Intellectual Property and Regulatory Trends |
|
14:00 |
Patent Issues for the Regnerative Medicine Field
Philippa Montgomerie, Associate, DLA Piper
How does the current climate impact on the ability to obtain patents for stem cell products and processes? How will the lifting of the ban on federal funding in the US affect the regenerative medicine industry in the UK? |
|
14:30 |
Stem Cells : The IP and Regulatory View
Patrick Kelleher, Partner, Bird & Bird
This presentation will discuss the legal position concering patentability of stem cells including the recent WARF/Thomson case (G2/06) from the European Patent Office . An overview of the European regulatory landscape for new stem cell treatments will also be provided. |
|
|
Session: Commercial Landscape |
|
15:00 |
Industry Landscape of Stem Cells for Cellular Therapy
Enal Razvi, Biotech Analyst, Select Biosciences
This presentation will present vignettes from our continuing industry tracking of stem cells. We will present data from our market analyses illustrating the penetrance of different types of stem cells for various cellular therapy applications. We will also discuss epigenetics and cellular reprogramming and its effect on the stem cells landscape. |
|
15:30 |
Coffee & Networking |
|
16:00 |
EUI Opportunities, Issues and Funding
Chirs Harris, Director, Argentix |
|
16:30 |
Commercialisation of hES Cells and Their Derivatives: The State of the Market
Fergus McKenzie, Programme Director, ITI Life Sciences |
|
17:00 |
Roslin Cellab: Providing the Opportunity to Explore and Exploit Stem Cell Biology
Laura Ingram, Manager, Roslin Cellab
Translating stem cell research into commercially valuable technologies requires proof of concept studies to be undertaken in a speedy and cost effective manner. This talk will describe the issues involved and how Roslin Cellab has been established to address them. |
|
17:30 |
Regenerative Medicine – Who are the End Users, What are their Needs and how does the Stem Cell Field Live up to Expectations?
Lars Pedersen, Director, Bioneer
In collaboration with a number of Danish companies, hospitals and universities Bioneer investigated the Danish and international landscape(s) of regenerative therapy. We have tried to figure out and will give our suggestions for how the society and industry may help in fulfilling the end users needs – end users being patients, their relatives, clinicians and companies. |
|
Day 2 - Thursday 24th September 2009 |
|
|
Session: Adult Stem Cells for Cellular Therapy and Regenerative Medicine |
|
9:00 |
Skeletal Muscle Stem Cells: Critical Roles in Growth, Regeneration and Repair
Claire Stewart, Professor, Manchester Metropolitan University
Despite being terminally differentiated, skeletal muscle is highly adaptable, responding to the demands placed upon it. The roles/mechansisms of resident stem cells in this adaptability, during health and disease and across the lifespan are crucial and will be discussed. |
|
9:30 |
Keynote Speaker
Therapeutic and Research Applications of Human Stem Cells
Stephen Minger, Professor, Kings College London
This presentation will provide an overview of the research and therapeutic potential of human stem cells including cell therapy applications as well as the use of stem cells in drug discovery and compound screening, toxicological assays and modernisation of traditional medicine for identification of new biological activities. |
|
10:00 |
Coffee & Networking in Main Exhibition Hall |
|
10:45 |
Epidermal Neural Crest Stem Cells
Maya Sieber-Blum, Professor, Newcastle University
Epidermal neural crest stem cells (EPI-NCSC) are remnants of the embryonic neural crest in an adult location, the bulge of hair follicles. They are multipotent adult stem cells, non-tumorigenic and conducive to autologous transplantation, which avoids graft rejection. |
|
11:15 |
Autologous Adult Stem Cells in Neurological Disorders
Nils Haberland, Neurosurgeon, Xcell Centre for Regenerative Medicine |
|
11:45 |
Poster Viewing Session |
|
12:15 |
Lunch & Networking in Main Exhibition Hall |
|
2:00 |
Title to be Confirmed
Brendan Noble, Professor, University of Edinburgh |
|
2:30 |
Stem Cell Therapeutic Strategies in Skeletal Regenerative Medicine
Comsimo De Bari, Professor, University of Aberdeen
MSC approaches to skeletal repair, including the use of culture-expanded MSCs, strategies to standardize MSC therapy via quality controls for efficacy, and possible manipulation of endogenous stem cell niches for treatment of joint surface lesions and prevention of osteoarthritis. |
|
Session: Emerging Trends in Stem Cell Research and Utilization of Stem Cells |
|
3:00 |
Can Extracellular Matrix Direct Stem Cell Differntiation: The Influence of Decellularized Lung Matrix on the Differentiation of Adult and Embryonic Stem Cells
Joaquin Cortiella, Associate Professor, University of Texas
Our work shows that decellularized natural lung can enhance differentiation of both embryonic and adult stem cells into lung lineages and also supports complex tissue formation leading to development of engineered lung. |
|
3:30 |
Coffee & Networking in Main Exhibition Hall |
|
4:15 |
Biodegradable Transfection Reagents: A Universal Solution
Asier Unciti-Broceta, Research Fellow, University of Edinburgh
This presentation will describe the development of a novel series of reagents capable of delivering nucleic acids into a variety of cell lines, including stem and primary cell lines, which were designed to degrade harmlessly into naturally-occurring cell components. |
|
4:45 |
Development of an in-vitro Analog of Human Bone Marrow
Joan Nichols, Associate Professor, University of Texas
Our research group has been working to develop In-vitro replicas of bone marrow to provide a continuous source of blood cells for transplantation or serve as a laboratory model to examine immune system dysfunctions and drug toxicology. |
|
5:15 |
European Stem Cell Law - Regulatory Trends in Regenerative Medicine
Timo Faltus, Translational Centre for Regenerative Medicine, University Leipzig |
|
5:45 |
Drinks Reception |
|
|
Day 3 - Friday 15th September 2009 |
|
9:00 |
Treatment of Plaque Infections and Periodontitis using Stem Cells
Manoj Harharan, Researcher, Rajalakshmi Engineering College
This presentation will focus on the Treatment of Periodontal and other dental infections using Stem cells. |
|
9:30 |
Tracing Cell Lineages and Identifying the Stem Cell Niche in Human Tissues
Malcolm Alison, Professor, Queen Mary University London
In human epithelial tissues, identifying stem cell niches, the stem cells themselves and lineage tracing from these stem cells has been practically impossible. I describe techniques for locating the niche and for lineage tracing, taking as exemplars intestine, liver, pancreas and skin. |
|
10:00 |
Plenary Speaker
Bench to Bedside - Stem Cells Transplantation
Paolo Macchiarini, Professor, University of Barcelona |
|
10:30 |
Coffee & Networking in Main Exhibition Hall |
|
11:15 |
MicroRNA 34-a is Modulated During Apoptosis-mediated Mouse Neural Stem Cell Differentiation
Marcia Aranha, Researcher, iMed.UL, Faculty of Pharmacy, University of Lisbon |
|
11:45 |
Keynote Speaker
Stem Cells in Brain Repair: Promoting Endogenous Repair or Supplying Exogenous Cells
Ian Duncan, Professor, University of Wisconsin Madison
Certain intractable CNS disorders may be targeted for stem cell therapy. Myelin disorders of genetic and acquired origin form a significant group of human neurological diseases. I will compare and contrast the sources of cells for myelin repair in MS and genetic disease of myelin. |
|
12:15 |
Poster Viewing Session |
|
12:45 |
Lunch & Networking in Main Exhibition Hall |
|
2:30 |
Keynote Speaker
Title to be Confirmed
Charles ffrench-Constant, Professor, University of Edinburgh |
|
3:00 |
Cartilage Tissue Engineering: Learning How to Turn Stem Cell Science into Stem Cell Medicine
Anthony Hollander, Professor, University of Bristol
This presentation will be an overview of cartilage engineering from adult and embryonic stem cells and translation of these laboratory methods into therapeutic strategies for a range of diseases. |
|
3:30 |
Coffee & Networking |
|
4:00 |
Title to be Confirmed
Sarah Rankin, Senior Lecturer, Imperial College London |
|
4:30 |
Title to be Confirmed |
|
5:00 |
Close of Conference | |